arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BIOCRYST PHARMACEUTICALS INC

BCRX

$8.55 ▼ -0.22 (-2.56%) at close

18 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Moderately Bullish

auto_awesome

Analytical Summary

BIOCRYST PHARMACEUTICALS INC demonstrates solid fundamentals with strength in Profit Margin (%). However, watch Return on Common Equity (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $1.8B

Dividend Yield —

Revenue Growth 94.1% ↗

Op. Margin 39.0% ↗

ROIC -282.4% ↘

FCF / Share $1.65 ↗

Trailing P/E 6.8x

Price / Book —

FCF Yield 19.4%

Debt / Equity 0.00

info Valuation on last close. End-of-day price, Sep 23, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$874.84M

↑ +94.1% —

Net Income Profit after all expenses

$263.86M

↑ +396.9% —

Operating Margin Operating profit as % of sales

39.0%

↑ +7008.2% 93th

FCF / Share Free cash flow per share

$1.65

↑ +757.6% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability

Returns

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	94.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1076%)	36.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+350%)	22.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+180%)	72.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+804%)	782.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9680%)	-63.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-894%)	136.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1606%)	-18.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-325%)	-4.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-155%)	-45.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-667%)	254.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3083%)	-21.5% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-369%)	-34.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-526%)	33.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+323%)	-68.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-956%)	-16.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-305%)	—	—
EPS Growth YoY (%)	N/M	63.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	11.3% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-29.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	60.8% Excellent ↑ Excellent Improving Year-over-year change in net income	8.3% Fair ↑ Fair Improving Year-over-year change in net income	-34.3% Weak ↓ Weak Declining Year-over-year change in net income	-0.7% Weak ↑ Weak Improving Year-over-year change in net income	-67.9% Weak ↓ Weak Declining Year-over-year change in net income	-7.6% Weak ↑ Weak Improving Year-over-year change in net income	-53.9% Weak ↓ Weak Declining Year-over-year change in net income	-19.3% Weak ↑ Weak Improving Year-over-year change in net income	-28.2% Weak ↓ Weak Declining Year-over-year change in net income	4.8% Caution ↑ Caution Improving Year-over-year change in net income	-50.1% Weak ↓ Weak Declining Year-over-year change in net income	23.0% Good ↑ Good Improving Year-over-year change in net income	31.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-68.2% Weak Weak Year-over-year change in net income	-151.7% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	49.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	43.1% Excellent Excellent Year-over-year change in free cash flow	-9.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	47.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	42.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	165.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	77.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	96.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-10.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	22.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-24.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	22.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	15.0% Good ↑ Good Improving Compound annual revenue growth over 3 years	22.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-11.5% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-34.7% Weak Weak Compound annual revenue growth over 3 years	-29.4% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	117.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	56.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	74.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	60.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	42.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-18.1% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	29.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	3.6% Caution ↑ Caution Improving Compound annual revenue growth over 5 years	-0.9% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	6.1% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	-5.0% Weak Weak Compound annual revenue growth over 5 years	-28.8% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	39.0% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+160%)	-0.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-104%)	-31.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-309%)	-54.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-465%)	-113.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-854%)	—	-203.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1458%)	-456.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3141%)	-227.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1620%)	-184.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1330%)	-81.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-645%)	-336.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2342%)	-177.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1282%)	-128.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-959%)	-252.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1783%)	-55.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-467%)	-18.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-223%)	—
Effective Tax Rate (%) (%)	1.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	30.2% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+151%)	-19.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-264%)	-68.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-670%)	-91.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-860%)	-117.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1076%)	—	-223.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1958%)	-490.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4185%)	-261.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2277%)	-209.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1844%)	-89.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-843%)	-332.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2867%)	-173.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1548%)	-148.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1339%)	-289.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2516%)	-54.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-552%)	-18.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-250%)	—
FCF Margin (%) (%)	39.7% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-11.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-28.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-59.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-90.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-184.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-450.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-163.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-202.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-142.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-164.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-45.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-21.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.32x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.42x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.21x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	-282.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	68.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	238.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-94.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-169.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-89.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-151.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-42.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2433.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-65.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-47.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2155.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	5896.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-264.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-12.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	66.3% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-0.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-30.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-52.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-56.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-64.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-54.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-62.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-59.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-60.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-31.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-221.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1576%)	18.7% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+25%)	49.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+232%)	83.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+459%)	172.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1047%)	—	-284.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1998%)	-205.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1471%)	-78.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-624%)	—	-90.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-701%)	-59.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-498%)	—	—	—	-51.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-445%)	-15.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	-0.66x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-210%)	-0.67x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-211%)	-0.79x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-231%)	-2.79x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-564%)	-6.37x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1161%)	1.31x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+118%)	—	0.27x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-54%)	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	14.37x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-0.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.96x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.50x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.05x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.36x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-10.27x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.70x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.49x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-7.59x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-9.16x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-6.43x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.26x Weak Weak Operating income divided by interest expense Optimal: > 5x	-13.14x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-89.74M	$210.16M	$192.59M	$-73.14M	$-206.25M	$-149.52M	$-64.17M	$-26.73M	$-27.28M	$-22.10M	$-28.90M	$-54.54M	$-21.16M	$-20.89M	$-16.44M	$-13.62M	$-41.12M	$-22.34M
Debt / EBITDA (x)	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-242.77x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.97x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.58x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.68x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.70x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.51x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.41x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$4.17	$2.18	$1.72	$1.46	$0.88	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$1.26	$-0.43	$-1.18	$-1.33	$-1.03	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$1.65	$-0.25	$-0.50	$-0.87	$-0.79	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.56	$-2.28	$-2.21	$-1.57	$-0.58	$-0.11	$0.25	$0.45	$0.85	$0.02	$0.65	$1.05	$-0.02	$-0.01	$0.32	$1.46	—	—
Tangible Book Value per Share (USD)	$-0.56	$-2.28	$-2.21	$-1.57	$-0.58	$-0.11	$0.25	$0.45	$0.85	$0.02	$0.65	$1.05	$-0.02	$-0.01	$0.32	$1.46	—	—
Basic Weighted Avg Shares (shares)	209.89M	206.70M	192.20M	185.91M	179.12M	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$208.28M	$261.58M	$345.98M	$410.99M	$462.42M	$218.15M	$72.01M	$44.88M	$50.55M	$12.63M	$1.54M	$31.66M	$26.86M	$24.75M	$26.56M	$59.42M	—	—
LT Debt (USD)	$0.00	$314.87M	$303.23M	$231.62M	$298.14M	$122.61M	$50.00M	—	$23.00M	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$-119.15M	$-475.93M	$-455.53M	$-294.60M	$-106.99M	$-19.26M	$38.25M	$49.23M	$83.77M	$1.58M	$47.72M	$75.64M	$-1.13M	$-454.00K	$14.81M	$65.50M	$86.27M	$46.43M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$874.84M	$450.71M	$331.41M	$270.83M	$157.17M	$17.81M	$48.84M	$20.65M	$25.19M	$26.35M	$48.26M	$13.61M	$17.33M	$26.29M	$19.64M	$62.38M	$74.59M	—
Depreciation Expense (USD)	$1.39M	$1.25M	$1.66M	$1.44M	$777.00K	$748.00K	$724.00K	$770.00K	$704.00K	$483.00K	$180.00K	$177.00K	$304.00K	$628.00K	$886.00K	—	—	—
Net Income, GAAP (USD)	$263.86M	$-88.88M	$-226.54M	$-247.12M	$-184.06M	$-182.81M	$-108.90M	$-101.25M	$-65.78M	$-55.14M	$-43.02M	$-45.19M	$-30.11M	$-39.08M	$-56.95M	$-33.85M	$-13.45M	—
Operating Cash Flow (USD)	$347.37M	$-52.02M	$-95.14M	$-161.85M	$-142.16M	$-135.11M	$-89.58M	$-92.56M	$-41.14M	$-53.44M	—	—	—	$-37.40M	$-32.25M	$-28.55M	$-16.22M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters

BIOCRYST PHARMACEUTICALS INC

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BCRX with peers